Where is Sydnexis located?

Sydnexis is located in Del Mar, United States .

Is Sydnexis a funded company?

Sydnexis is a funded company, its first funding round was on Oct 19, 2017.

When was the latest funding round of Sydnexis?

Sydnexis's latest funding round was on Apr 03, 2025.

Where does Sydnexis rank among its competitors?

Sydnexis ranks 9 amongst 88 active competitors.

Who are the top competitors of Sydnexis?

Sydnexis' top competitors are 4D Molecular Therapeutics, EyePoint Pharmaceuticals and Rezolute.

Sydnexis - 2025 Company Profile, Funding & Competitors

Company Details

Sydnexis has developed a proprietary formulation for treating myopia. The patented eye drop formulation SYD-101 is developed to reduce the myopia progression which is associated with numerous serious ophthalmic co-morbidities in children.

Website
Email ID: @sydnexis.com
Phone Number: +1

Key Metrics

Founded Year

2014

Location

Del Mar, United States

Stage

Series B

Total Funding

in 4 rounds

Latest Funding Round

Investors

Bluestem Capital & 5 more

Ranked

9^th among

Similar Companies

4D Molecular Therapeutics &

Get your free copy of Sydnexis's company profile

Sydnexis has raised a total funding of $71.5M over 4 rounds. Its first funding round was on Oct 19, 2017.

Sydnexis has 6 institutional investors including Bluestem Capital, Visionary Ventures and SC Master Fund.

Here is the list of recent funding rounds of Sydnexis:

Date of funding	Funding Amount	Round Name	Post money valuation	Revenue multiple	Investors
Apr 03, 2025	$20M	Series B	8072584	1702978	-
Apr 24, 2024	$1M	Series B	9051482	3804099	-
Aug 10, 2021	$45M	Series B	8090938	8975410	Visionary Ventures, SC Master Fund, and

Access funding benchmarks and valuations. Sign up today!

View details of Sydnexis's funding rounds and investors

The founders of Sydnexis is .

View details of Sydnexis's Founder profiles and Board Members

Top competitors of Sydnexis include 4D Molecular Therapeutics, EyePoint Pharmaceuticals and Rezolute. Here is the list of Top 10 competitors of Sydnexis, ranked by 秘密研究所 score :

Overall Rank	Company Details	Short Description	Total Funding	Investors	秘密研究所 Score
1st	4D Molecular Therapeutics 2013, Emeryville (United States), Public	Developer of gene therapeutics for genetic disorders	$187M	Pfizer, 听&补尘辫;听	66/100
2nd	EyePoint Pharmaceuticals 1987, Watertown (United States), Public	Developer of small molecule-based therapeutics for treating ophthalmic disorders	-	OcuMension, Rosalind Advisors听&补尘辫;听	65/100
3rd	Rezolute 2012, Denver (United States), Public	Biopharmaceutical company developing therapies for metabolic & orphan diseases	-	CAM Capital, 听&补尘辫;听	61/100
4th	Molecular Partners 2004, Zurich (Switzerland), Public	Developer of therapeutic solutions for treating multiple diseases	$59.9M	Johnson & Johnson Innovation 鈥� JJDC, BB Biotech Ventures听&补尘辫;听	58/100
5th	Aviceda Therapeutics 2018, Cambridge (United States), Series C	Developer of biotherapeutics for glycol-immune diseases	$255M	abrdn, Marshall Wace听&补尘辫;听	58/100
6th	Epicrispr Bio 2018, San Francisco (United States), Series B	Developer of therapeutics for multiple disease	$68M	Ally Bridge Group, LDV Partners听&补尘辫;听	55/100
7th	Relmada 2007, Blue Bell (United States), Public	Developing novel drug products for the treatment of multiple disease	$13M	Olympus Capital Investments, BioAdvance听&补尘辫;听	55/100
8th	CureVac 2000, Tubingen (Germany), Public	Developer of mRNA-based therapeutics against cancer and infectious diseases	$975M	European Investment Bank, 听&补尘辫;听	54/100
9th	2014, Del Mar (United States), Series B	Developer of a therapeutic formulation for treating myopia	$71.5M	Visionary Ventures, Longitude Capital听&补尘辫;听	54/100
10th	EyeBio 2021, London (United Kingdom), Acquired	Developer of therapies to treat ophthalmological diseases	$130M	MRLV, Vertex Ventures HC听&补尘辫;听	53/100